Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,03%
1 094,12
+0,31
+0,03%
—1 093,811 096,521 100,221 093,20——
SIXC
Communications
SIXC
Communications
SIXC
+0,45%
611,52
+2,75
+0,45%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,24%
1 239,24
-15,57
-1,24%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,67%
1 749,30
-11,81
-0,67%
—1 761,111 764,271 766,881 745,39——
SIXM
Financials
SIXM
Financials
SIXM
-0,04%
642,35
-0,23
-0,04%
—642,58644,87648,48641,40——
SIXR
Staples
SIXR
Staples
SIXR
-0,24%
849,12
-2,01
-0,24%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,12%
217,71
-0,27
-0,12%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,68%
3 265,86
+54,03
+1,68%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,45%
944,72
-4,26
-0,45%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,41%
1 468,43
-6,09
-0,41%
—1 474,521 479,031 481,041 467,58——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,40%
2 401,80
+9,68
+0,40%
—2 392,122 396,952 421,222 382,32——
29A:FRA
Amphastar Pharmaceuticals, Inc
€17,93
-1,40%
(-0,25) 1D
30 Apr., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 29A...
Open
€17,93
High
€17,93
Low
€17,93
Mkt. cap
976,21 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€25,96
52-wk low
€15,26
No. of employees
2 k
News stories
From sources across the web
Profile
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally. In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case. In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia
About Amphastar Pharmaceuticals, Inc
CEO-
Employees1,98 k
Founded1996
HeadquartersRancho Cucamonga, Kalifornië, Verenigde State van Amerika
SectorPharmaceutical industry
Websiteamphastar.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
170,53 m
174,41 m
191,84 m
183,10 m
Cost of goods sold
85,28 m
87,92 m
93,19 m
97,44 m
Cost of revenue
85,28 m
87,92 m
93,19 m
97,44 m
Research and development expenses
20,10 m
20,08 m
22,35 m
23,31 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,86 m
24,23 m
27,87 m
26,75 m
Operating expense
47,96 m
44,31 m
50,23 m
50,06 m
Total operating expenses
133,24 m
132,23 m
143,42 m
147,50 m
Operating income
37,29 m
42,18 m
48,42 m
35,61 m
Other non operating income
666,00 k
-189,00 k
231,00 k
215,00 k
EBT including unusual items
30,86 m
39,34 m
21,51 m
31,91 m
EBT excluding unusual items
30,86 m
39,34 m
44,61 m
31,91 m
Income tax expense
5,58 m
8,30 m
4,16 m
7,48 m
Effective tax rate
18,07%
21,11%
19,35%
23,45%
Other operating expenses
-
-
-
-
Net income
25,28 m
31,03 m
17,35 m
24,43 m
Net profit margin
14,83%
17,79%
9,04%
13,34%
Earnings per share
0,74
0,85
0,93
0,73
Interest and investment income
2,09 m
1,92 m
2,25 m
2,42 m
Interest expense
-9,19 m
-4,58 m
-6,28 m
-6,33 m
Net interest expenses
-7,10 m
-2,66 m
-4,04 m
-3,91 m
Depreciation and amortization charges
-
-
-
-
EBITDA
50,90 m
56,80 m
62,55 m
49,95 m
Gain or loss from assets sale
2,00 k
30,00 k
1,00 k
6,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer